Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets
- 12 May 2004
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 86 (4) , 239-245
- https://doi.org/10.1111/j.0042-9007.2004.00419.x
Abstract
Background and Objectives The INTERCEPT Blood System for Platelets utilizes amotosalen–HCl (S‐59) in combination with ultraviolet A (UVA) light to inactivate viruses, bacteria, protozoa and leucocytes that may contaminate platelet concentrates (PCs). To facilitate implementation of this technique into routine blood bank manufacturing procedures, this study evaluated the impact of different time settings of photochemical treatment onin vitroplatelet function.Materials and Methods Platelets derived from apheresis (6·5–7·0 × 1011platelets) were resuspended in 240 ml of autologous plasma and 360 ml of platelet additive solution (PAS III) and split into two equal‐sized PC units. Whereas one unit was not treated, the other was treated with 150 µmamotosalen and 3 J/cm2UVA light followed by a compound adsorption device (CAD) step for reduction of residual amotosalen and photoproducts. In a first series of experiments (arm A,n = 7), PC units were photochemically treated after an overnight storage period of 16–23 h followed by a CAD step of 4 h. In a second series (arm B,n = 8), photochemical treatment occurred after a short storage time of 4 h with a subsequent CAD step of 16 h. Platelet function was evaluated by assaying blood gas analysis, glucose and lactate concentration, lactate dehydrogenase (LDH), hypotonic shock response (HSR) and the expression of CD62p, over a period of 7 days.Results Neither of the photochemical treatment procedures showed differences for pH, pCO2, pO2, HCO3, glucose consumption or platelet activation until the end of day 7. Increased lactate values detected for the treated units of arm A at the end of the storage period were independent from the PCT time setting.Conclusions Photochemical pathogen inactivation with different initial resting periods between 4 and 23 h, and different CAD steps of 4 and 16 h, had no influence on the plateletin vitrofunction during 7 days of storage.Keywords
This publication has 18 references indexed in Scilit:
- Storage Characteristics of Split Double-Dose Platelet Concentrates Derived from Apheresis and Treated with Amotosalen Hydrochloride and UVA Light for Pathogen InactivationTransfusion Medicine and Hemotherapy, 2002
- Determinants of transfusion‐associated bacterial contamination: results of the French Bacthem Case‐Control StudyTransfusion, 2001
- Inactivation of infectious pathogens in labile blood components: meeting the challengeTransfusion Clinique et Biologique, 2001
- Pathogen inactivation of labile blood productsTransfusion Medicine, 2001
- Functional Characteristics of S-59 Photochemically Treated Platelet Concentrates Derived from Buffy CoatsPublished by Wiley ,2000
- Effects of methylene blue‐treated plasma on red cells and stored platelet concentratesTransfusion, 1999
- Photochemical Treatment of Platelet Concentrates with a Novel Psoralen and UVA to Enhance the Safety of Platelet TransfusionsaTransfusion Medicine and Hemotherapy, 1998
- A multi‐laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood TransfusionTransfusion, 1998
- Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long‐wavelength ultraviolet lightTransfusion, 1997
- BACTERIAL CONTAMINATION OF CELLULAR BLOOD COMPONENTSVox Sanguinis, 1994